Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 20, 2022

SELL
$3.17 - $4.09 $5.49 Million - $7.08 Million
-1,730,607 Closed
0 $0
Q2 2021

Aug 03, 2021

SELL
$2.86 - $3.61 $2.5 Million - $3.16 Million
-875,000 Reduced 33.58%
1,730,607 $5.49 Million
Q4 2020

Jan 15, 2021

SELL
$1.82 - $2.61 $627,166 - $899,398
-344,597 Reduced 11.68%
2,605,607 $6.57 Million
Q3 2020

Oct 23, 2020

SELL
$2.02 - $3.02 $538,330 - $804,830
-266,500 Reduced 8.28%
2,950,204 $6.23 Million
Q2 2020

Jul 24, 2020

SELL
$2.12 - $3.22 $1.68 Million - $2.55 Million
-791,147 Reduced 19.74%
3,216,704 $7.21 Million
Q3 2019

Nov 12, 2019

BUY
$3.01 - $4.0 $1.27 Million - $1.68 Million
420,600 Added 11.72%
4,007,851 $14.4 Million
Q2 2019

Aug 09, 2019

SELL
$2.79 - $4.31 $2.79 Million - $4.31 Million
-999,168 Reduced 21.79%
3,587,251 $12.1 Million
Q1 2019

May 08, 2019

BUY
$2.54 - $4.02 $148,844 - $235,571
58,600 Added 1.29%
4,586,419 $12.5 Million
Q4 2018

Feb 11, 2019

SELL
$2.46 - $4.2 $84,833 - $144,837
-34,485 Reduced 0.76%
4,527,819 $12.6 Million
Q3 2018

Nov 13, 2018

BUY
$3.81 - $5.53 $3.44 Million - $4.99 Million
903,155 Added 24.68%
4,562,304 $18.8 Million
Q3 2018

Nov 08, 2018

SELL
$3.81 - $5.53 $4.15 Million - $6.02 Million
-1,088,755 Reduced 22.93%
3,659,149 $15.1 Million
Q2 2018

Aug 07, 2018

SELL
$5.06 - $6.78 $252,999 - $339,000
-50,000 Reduced 1.04%
4,747,904 $24.6 Million
Q1 2018

May 09, 2018

BUY
$5.43 - $8.36 $1.28 Million - $1.97 Million
235,129 Added 5.15%
4,797,904 $26.3 Million
Q4 2017

Jan 23, 2018

BUY
$8.15 - $10.55 $7.15 Million - $9.26 Million
877,255 Added 23.8%
4,562,775 $37.2 Million
Q3 2017

Nov 08, 2017

BUY
$10.45 - $11.44 $38.5 Million - $42.2 Million
3,685,520
3,685,520 $38.6 Million

Others Institutions Holding ENZ

About ENZO BIOCHEM INC


  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $51.6M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Evermore Global Advisors, LLC Portfolio

Follow Evermore Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evermore Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evermore Global Advisors, LLC with notifications on news.